Literature DB >> 22527912

Geographical distribution of plakophilin-2 mutation prevalence in patients with arrhythmogenic cardiomyopathy.

K A Jacob1, M Noorman, M G P J Cox, J A Groeneweg, R N W Hauer, M A G van der Heyden.   

Abstract

Arrhythmogenic cardiomyopathy (AC) is characterised by myocardial fibrofatty tissue infiltration and presents with palpitations, ventricular arrhythmias, syncope and sudden cardiac death. AC is associated with mutations in genes encoding the desmosomal proteins plakophilin-2 (PKP2), desmoplakin (DSP), desmoglein-2 (DSG2), desmocollin-2 (DSC2) and junctional plakoglobin (JUP). In the present study we compared 28 studies (2004-2011) on the prevalence of mutations in desmosomal protein encoding genes in relation to geographic distribution of the study population. In most populations, mutations in PKP2 showed the highest prevalence. Mutation prevalence in DSP, DSG2 and DSC2 varied among the different geographic regions. Mutations in JUP were rarely found, except in Denmark and the Greece/Cyprus region.

Entities:  

Year:  2012        PMID: 22527912      PMCID: PMC3346879          DOI: 10.1007/s12471-012-0274-x

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  40 in total

1.  Task Force on Sudden Cardiac Death of the European Society of Cardiology.

Authors:  S G Priori; E Aliot; C Blomstrom-Lundqvist; L Bossaert; G Breithardt; P Brugada; A J Camm; R Cappato; S M Cobbe; C Di Mario; B J Maron; W J McKenna; A K Pedersen; U Ravens; P J Schwartz; M Trusz-Gluza; P Vardas; H J Wellens; D P Zipes
Journal:  Eur Heart J       Date:  2001-08       Impact factor: 29.983

2.  Clinical expression of plakophilin-2 mutations in familial arrhythmogenic right ventricular cardiomyopathy.

Authors:  Petros Syrris; Deirdre Ward; Angeliki Asimaki; Srijita Sen-Chowdhry; Hatim Y Ebrahim; Alison Evans; Nobuhiko Hitomi; Mark Norman; Antonios Pantazis; Anthony L Shaw; Perry M Elliott; William J McKenna
Journal:  Circulation       Date:  2006-01-16       Impact factor: 29.690

3.  Role of genetic testing in arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Authors:  C Barahona-Dussault; B Benito; O Campuzano; A Iglesias; T L Leung; L Robb; M Talajic; R Brugada
Journal:  Clin Genet       Date:  2009-10-15       Impact factor: 4.438

4.  Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  Zhao Yang; Neil E Bowles; Steven E Scherer; Michael D Taylor; Debra L Kearney; Shuping Ge; Vyacheslav V Nadvoretskiy; Gilberto DeFreitas; Blasé Carabello; Lois I Brandon; Lisa M Godsel; Kathleen J Green; Jeffrey E Saffitz; Hua Li; Gian Antonio Danieli; Hugh Calkins; Frank Marcus; Jeffrey A Towbin
Journal:  Circ Res       Date:  2006-08-17       Impact factor: 17.367

5.  Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  J Peter van Tintelen; Mark M Entius; Zahurul A Bhuiyan; Roselie Jongbloed; Ans C P Wiesfeld; Arthur A M Wilde; Jasper van der Smagt; Ludolf G Boven; Marcel M A M Mannens; Irene M van Langen; Robert M W Hofstra; Luuk C Otterspoor; Pieter A F M Doevendans; Luz-Maria Rodriguez; Isabelle C van Gelder; Richard N W Hauer
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

6.  Population-prevalent desmosomal mutations predisposing to arrhythmogenic right ventricular cardiomyopathy.

Authors:  Annukka M Lahtinen; Eero Lehtonen; Annukka Marjamaa; Maija Kaartinen; Tiina Heliö; Kimmo Porthan; Lasse Oikarinen; Lauri Toivonen; Heikki Swan; Antti Jula; Leena Peltonen; Aarno Palotie; Veikko Salomaa; Kimmo Kontula
Journal:  Heart Rhythm       Date:  2011-03-10       Impact factor: 6.343

Review 7.  Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  Srijita Sen-Chowdhry; Petros Syrris; William J McKenna
Journal:  J Am Coll Cardiol       Date:  2007-10-24       Impact factor: 24.094

8.  Mutations of plakophilin-2 in Chinese with arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  Xiaoliang Qiu; Wenling Liu; Dayi Hu; Tiangang Zhu; Cuilan Li; Lei Li; Chengjun Guo; Xingpeng Liu; Lei Wang; Hua Zheng; Chunling Wang; Qing Diao; Dan Shi; Pingyun Zhan; Yuanming Deng; Kunshen Liu; Yi Wang; Baomin Liu; Hongming Liu; Li Zhang
Journal:  Am J Cardiol       Date:  2009-04-01       Impact factor: 2.778

Review 9.  Arrhythmogenic right ventricular cardiomyopathy.

Authors:  Cristina Basso; Domenico Corrado; Frank I Marcus; Andrea Nava; Gaetano Thiene
Journal:  Lancet       Date:  2009-04-11       Impact factor: 79.321

10.  Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1.

Authors:  Giorgia Beffagna; Gianluca Occhi; Andrea Nava; Libero Vitiello; Andrea Ditadi; Cristina Basso; Barbara Bauce; Gianni Carraro; Gaetano Thiene; Jeffrey A Towbin; Gian Antonio Danieli; Alessandra Rampazzo
Journal:  Cardiovasc Res       Date:  2005-02-01       Impact factor: 10.787

View more
  6 in total

1.  Genetic Variant Score and Arrhythmogenic Right Ventricular Cardiomyopathy Phenotype in Plakophilin-2 Mutation Carriers.

Authors:  Anneli Svensson; Pyotr G Platonov; Kristina H Haugaa; Wojciech Zareba; Henrik Kjærulf Jensen; Henning Bundgaard; Thomas Gilljam; Trine Madsen; Jim Hansen; Lars A Dejgaard; Lars O Karlsson; Anna Gréen; Bronislava Polonsky; Thor Edvardsen; Jesper Hastrup Svendsen; Cecilia Gunnarsson
Journal:  Cardiology       Date:  2021-09-01       Impact factor: 1.869

2.  Compendium of causative genes and their encoded proteins for common monogenic disorders.

Authors:  Tucker L Apgar; Charles R Sanders
Journal:  Protein Sci       Date:  2021-09-21       Impact factor: 6.993

3.  Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia (ARVC/D): Review of 16 Pediatric Cases and a Proposal of Modified Pediatric Criteria.

Authors:  Shriprasad R Deshpande; Haley K Herman; Phillip C Quigley; Julia K Shinnick; Caitlin A Cundiff; Shelley Caltharp; Bahig M Shehata
Journal:  Pediatr Cardiol       Date:  2016-01-08       Impact factor: 1.655

4.  Arrhythmogenic right ventricular cardiomyopathy in patients with biallelic JUP-associated skin fragility.

Authors:  Hassan Vahidnezhad; Leila Youssefian; Masoomeh Faghankhani; Nikoo Mozafari; Amir Hossein Saeidian; Fatemeh Niaziorimi; Fahimeh Abdollahimajd; Soheila Sotoudeh; Fateme Rajabi; Liaosadat Mirsafaei; Zahra Alizadeh Sani; Lu Liu; Alyson Guy; Sirous Zeinali; Ariana Kariminejad; Reginald T Ho; John A McGrath; Jouni Uitto
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

5.  Arrhythmogenic cardiomyopathy: diagnosis, genetic background, and risk management.

Authors:  J A Groeneweg; J F van der Heijden; D Dooijes; T A B van Veen; J P van Tintelen; R N Hauer
Journal:  Neth Heart J       Date:  2014-08       Impact factor: 2.380

6.  Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy.

Authors:  Giovanni Donato Aquaro; Antonio De Luca; Chiara Cappelletto; Francesca Raimondi; Francesco Bianco; Nicoletta Botto; Andrea Barison; Simona Romani; Pierluigi Lesizza; Enrico Fabris; Giancarlo Todiere; Crysanthos Grigoratos; Alessandro Pingitore; Davide Stolfo; Matteo Dal Ferro; Marco Merlo; Gianluca Di Bella; Gianfranco Sinagra
Journal:  ESC Heart Fail       Date:  2020-09-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.